Infectologia

Reino Unido, Espanha e Portugal relatam mais casos de varíola dos macacos.

20 Mai, 2022 | 14:16h

UK, Spain, Portugal report more monkeypox cases – CIDRAP

Ver também:

U.S. monkeypox case reported, as Spain, Portugal report infections in growing outbreak – STAT

Monkeypox – United Kingdom of Great Britain and Northern Ireland – World Health Organization

Monkeypox cases confirmed in England – latest updates – UK Health Security Agency

Seven Confirmed Monkeypox Cases in UK Includes Sexually Transmitted Cluster – Health Policy Watch

European outbreak of monkeypox: what you need to know – The Conversation

Rare monkeypox outbreak in U.K., Europe and U.S.: What is it and should we worry – NPR

Monkeypox cases under investigation in Canada as outbreak spreads in Europe, U.S. – CBC News

 

Comentário no Twitter

On the rare monkeypox outbreak in Europe!
Health officials have little clue where people caught the virus. And there's concern the virus may be spreading through the community – undetected – and possibly through a new route of transmission #IDTwitter https://t.co/KOQ8rM2nW9

— Antibiotic Steward Bassam Ghanem🆔🔥 (@ABsteward) May 18, 2022

 

---

Opinião | Paxlovid ajuda as pessoas vacinadas contra Covid-19? Mostrem-nos os dados!

20 Mai, 2022 | 14:10h

Does Paxlovid help people who have been vaccinated against Covid-19? Show us the data! – STAT

---

Revisão | Síndromes infecciosas pós-agudas inexplicadas.

20 Mai, 2022 | 14:07h

Unexplained post-acute infection syndromes – Nature Medicine (se o acesso a este link for pago, tente este)

 

Comentário no Twitter

A @NatureMedicine tour de force review of the unexplained post-acute infectious syndromes, which includes #LongCovid and many others https://t.co/5RnyY9l0eQ
by @jan_choutka @mhornig @VirusesImmunity pic.twitter.com/dhYeZYnM1U

— Eric Topol (@EricTopol) May 18, 2022

 

---

Opinião | Bill Gates e o destino da OMS.

20 Mai, 2022 | 14:05h

Offline: Bill Gates and the fate of WHO – The Lancet

 

Comentário no Twitter

Offline: Bill Gates and the fate of WHO https://t.co/KKUkdFteUN An oped by @richardhorton1 in @TheLancet which he criticizes both @BillGates & @WHO on their positions to the future of pandemic responses.

— Carlos del Rio (@CarlosdelRio7) May 13, 2022

 

---

Revisão sistemática | Prevalência mundial dos vírus das hepatites B e C em pacientes com cirrose por país, região e globalmente.

20 Mai, 2022 | 14:04h

Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review – The Lancet Gastroenterology & Hepatology

---

Uso de antibióticos antes do parto cesariano não está ligado a asma e eczema em crianças pequenas.

20 Mai, 2022 | 13:58h

Comunicado de imprensa: Antibiotics given shortly before cesarean birth not linked to asthma and eczema in young children – University of Birmingham

Estudo original: Long term impact of prophylactic antibiotic use before incision versus after cord clamping on children born by caesarean section: longitudinal study of UK electronic health records – The BMJ

---

OMS | Segundo reforço da vacina contra COVID para os mais vulneráveis oferece benefícios.

19 Mai, 2022 | 13:15h

WHO: 2nd COVID booster for most vulnerable offers benefits – World Health Organization

---

Cães farejadores na detecção de COVID-19: estudo randomizado triplo-cego em ambiente aeroportuário.

19 Mai, 2022 | 13:14h

Scent dogs in detection of COVID-19: triple-blinded randomised trial and operational real-life screening in airport setting – BMJ Global Health

Comunicado de imprensa: Trained sniffer dogs accurately detect people infected with SARS-CoV-2 – BMJ Newsroom

Comentário: Trained scent dogs detect airline travelers with COVID-19 – CIDRAP

---

[Preprint] Efetividade do segundo reforço da vacina contra COVID-19 sobra a mortalidade por todas as causas em residentes de instituições de cuidado de longo prazo e em idosos mais velhos: estudo nacional de coorte retrospectiva na Suécia.

19 Mai, 2022 | 13:13h

Effectiveness of a Second COVID-19 Vaccine Booster on All-Cause Mortality in Long-Term Care Facility Residents and in the Oldest Old: A Nationwide, Retrospective Cohort Study in Sweden – Preprints with The Lancet

 

Comentário no Twitter

Confirmation of the 2nd booster protection from death in people age 80+ in Sweden, with a relative vaccine effectiveness 42% (compared w/ the 1st booster)https://t.co/Dq1x00J3Tr pic.twitter.com/fyXJPEcQzC

— Eric Topol (@EricTopol) May 17, 2022

 

---

Tratamento das interações medicamentosas com nirmatrelvir/ritonavir (Paxlovid).

19 Mai, 2022 | 13:08h

Management of Drug Interactions With Nirmatrelvir/Ritonavir (Paxlovid®): Resource for Clinicians – Infectious Diseases Society of America

Comentário: IDSA offers guidance on managing drug interactions with nirmatrelvir/ritonavir – ACP Internist

Conteúdos relacionados:

Paxlovid’s failure as a preventative measure raises questions, but doctors still back it as a therapeutic – STAT

Yes, Relapses After Paxlovid Happen — Now What? – HIV and ID Observations

Covid-19: What is the evidence for the antiviral Paxlovid? – The BMJ

Yes, Relapses After Paxlovid Happen — Now What? – HIV and ID Observations

WHO recommends highly successful COVID-19 therapy and calls for wide geographical distribution and transparency from originator – World Health Organization

A living WHO guideline on drugs for covid-19 – The BMJ

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 – New England Journal of Medicine

Prescribing Nirmatrelvir–Ritonavir: How to Recognize and Manage Drug–Drug Interactions – Annals of Internal Medicine

The COVID-19 Treatment Guidelines Panel’s Statement on Potential Drug-Drug Interactions Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Concomitant Medications – NIH COVID-19 Treatment Guidelines Panel

---